china glp 1 market GLP-1 Agonists Report 2025-2033, By Product, Molecule, and Geo GLP-1 Market Size, Scope, Forecast
Description
Subscribe: save, and pause or cancel anytime
Participants received diet (500kcaldeficit per day) and exercise counseling during 2-week run-in, before being randomly assigned (with a telephone or web-based system) to once-daily subcutaneous liraglutide (1.2, 1.8, 2.4 or 3.0mg, n=9095), placebo (n=98) or open-label orlistat (120mg 3, n=95)
Lower volume when food feels harder
Have you jumped in yet
See individual product labels for complete exclusion details
